| MDT | mast [cell] degeneration test; mean dissolution time; median detection threshold; multidisciplinary ... |
|---|---|
| MID | maximum inhibiting dilution; mesioincisodistal; midinfarct dementia; minimum infective dose; minimum... |
| NDT | neurodevelopmental treatment; noise detection threshold; nondestructive test, nondestructive testing... |
| PLD | peripheral light detection; phospholipase D; platelet defect; polycystic liver disease; posterior la... |
| SDM | sensory detection method; standard deviation of the mean |
| compact substance | The compact, noncancellous portion of bone that consists largely of concentric lamellar osteons and interstitial lamellae. Synonym: substantia compacta, compact substance, substantia compacta ossium. (05 Mar 2000) |
|---|---|
| white substance | <anatomy> Brain tissue composed of myelin-coated nerve cell fibres. White matter carries information between the nerve cells in the brain and spinal cord. The inner portion of the cerebrum is composed of white matter. See: grey matter. (13 Nov 1997) |
| mullerian inhibiting substance | A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin. Synonym: mullerian inhibiting factor. (05 Mar 2000) |
| muscular substance of prostate | The smooth muscle in the stroma of the prostate. Synonym: substantia muscularis prostatae, musculus prostaticus. (05 Mar 2000) |
| controlled substance | A substance subject to the Controlled Substances Act (1970), which regulates the prescribing and dispensing, as well as the manufacturing, storage, sale, or distribution of substance's assigned to five schedules according to their 1) potential for or evidence of abuse, 2) potential for psychic or physiologic dependence, 3) contributing a public health risk, 4) harmful pharmacologic effect, or 5) role as a precursor of other controlled substance's. (05 Mar 2000) |
| cortical substance | The superficial thin layer of compact bone. Synonym: substantia corticalis, cortical substance. (05 Mar 2000) |
| posterior perforated substance | The bottom of the interpeduncular fossa at the base of the midbrain, extending from the anterior border of the pons forward to the mamillary bodies, and containing numerous openings for the passage of perforating branches of the posterior cerebral arteries. Synonym: substantia perforata posterior, locus perforatus posticus, Malacarne's space. (05 Mar 2000) |
| pressor substance | One of several products of intestinal putrefaction believed to cause functional hypertension when absorbed, any alkaline substance that raises blood pressure. Synonym: pressor amine, pressor substance. (05 Mar 2000) |
| proper substance | See: substantia propria of cornea, substantia propria membranae tympani, substantia propria sclerae. (05 Mar 2000) |
| schwann's white substance | <anatomy> The substance of the medullary sheath. Source: Websters Dictionary (01 Mar 1998) |
| psychoses, substance-induced | Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. (12 Dec 1998) |
| sensitizing substance | Antibody that combines with and sensitises antigen leading to the activation of complement, which may result in cell lysis. Synonym: CF antibody, sensitizing substance. (05 Mar 2000) |
| h substance | <haematology> A polysaccharide precursor molecule which is used to make the antigens on the surface of human blood cells that are classified in the ABO blood group system. (09 Oct 1997) |
| slow-reacting substance | Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules. Compare: peptidyl leukotrienes. Synonym: slow-reacting factor of anaphylaxis. (05 Mar 2000) |
| slow reacting substance of anaphylaxis | <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma. A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4) (18 Nov 1997) |